Children with genetic diseases and cancers will be given faster access to life-saving gene and cell therapies through a new commercial scale viral vector manufacturing facility in Western Sydney.
The NSW government has called on industry and investors to submit expressions of interest to support the growth and operations of the facility, to be built in the Westmead Health and Innovation Distri...
News & Events
Two young sisters with a blinding eye condition will now have access to ocular gene therapy after a new pathway to the treatment was discovered.
The girls, who were diagnosed with early-onset severe retinal dystrophy (EOSRD), an inherited degenerative disease of the retina, began having trouble with their night vision at four and two years of age.
With few effective treatments available for...
New research has shown that gene therapy may provide an effective treatment for Spinal Muscular Atrophy (SMA), a devastating and fatal genetic condition. The first part of the results from the SPR1NT trial were presented at the European Academy of Neurology (EAN) Conference recently.
What is SMA?
SMA affects the motor nerve cells in the spinal cord, causing progressive muscle weakness...
The Sydney Children’s Hospitals Network (SCHN) and Children’s Medical Research Institute (CMRI) are pleased to announce the establishment of the Australian Genome Therapeutics Centre (AGTC), which will transform the treatment of children with serious inherited diseases and contribute to the development of exciting new treatment options for a wide range of other diseases, including cancer, across...
A gene therapy project to save infants’ lives has been named the top-ranked National Health and Medical Research Council (NHMRC) Ideas Grant for 2020. The project led by Professor Ian Alexander and his team were awarded the 2020 NHMRC Marshall and Warren Ideas Grant Award at the NHMRC Research Excellence Awards Dinner on June 16th.
Professor Ian Alexander, Head of the Gene Therapy Research Uni...
International Clinical Trials Day is celebrated around the world in May to acknowledge and celebrate the many people who are involved in clinical trials. It is also a unique opportunity to raise awareness about the importance of clinical trials and clinical research as a career option – among the greater public. Learn more about Clinical Trials Day here
Read the words written by Aimee Williams...
Watch the video of this webinar to hear from two experts in the fields of genetic retinal diseases and stem cell biology discuss Ocular Gene and Cell Therapies and the tremendous new hope they bring to the treatment of these retinal diseases.
Ocular Gene Therapy is the first in vivo gene therapy approved by the Therapeutic Goods Administration (TGA) here in Australia for clinical use...
Registration now open!
Register now and join our 3rd webinar of the Advanced Therapeutics series. In this webinar, we will be focusing on Ocular Gene Therapy, the first in vivo gene therapy approved by the Therapeutic Goods Administration (TGA) here in Australia for clinical use in inherited retinal diseases. Inherited retinal diseases are a group of conditions that disproportionately affect c...
World Purple Day is celebrated on the 26th March, a day aimed at raising awareness of epilepsy.
What is Epilepsy?
Epilepsy is one of the most common neurological disorder that affects the brain, often causing seizures. Around 65 million people in the world have epilepsy and although epilepsy can develop at any stage of life, it is more common in children, adolescents and people over 60....
Missed out on our first webinar of the year? Watch the video of this webinar to hear from two esteemed leaders in the field of paediatric cancer and pioneers in CAR-T cell therapy.
Chimeric Antigen Receptor (CAR) T cell therapy is the most therapeutic advancement in acute lymphoblastic leukaemia for generations and is a new form of immunotherapy approach to cancer. The CAR-T cell therapy appro...